Back

Impact of LVEF and de novo heart failure on outcomes of SGLT2 inhibitor therapy initiated during acute heart failure

11 May 2026 (16:02 - 16:10)
Organised by: Logo
Congress Presentation Part of: Medical treatment in acute heart failure Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ana Marta Castro Pinto

Hospital Guimaraes, Guimaraes (Portugal)

5 More presentations in this session

Presentation thumbnail
Association of poor adherence to guideline-directed medical treatment with adverse events including fatal arrhythmia in heart failure with reduced ejection fraction: A nationwide cohort analysis
Doctor M. Kim (Goyang, KR)
Abstract Slides Video
Presentation thumbnail
Dapagliflozin in patients hospitalised with newly diagnosed heart failure: an analysis of the randomized DAPA ACT HF-TIMI 68 trial
Doctor P. Haller (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
The O-GlcNAcase inhibitor ASN90 opposes acute cardiac decompensation in rats with chronic heart failure.
Doctor G. Vincent (Rouen, FR)
Abstract Video
Presentation thumbnail
Impact of Dapaglizofin on right ventricular function and pulmonary pressure: a secondary analysis of the RIVED registry
Associate Professor A. Palazzuoli (Siena, IT)
Abstract Slides Video
Presentation thumbnail
Potentially inappropriate medications in older adults with heart failure: prevalence and predictors using the 2023 Beers Criteria
Doctor M. Sheikh-Taha (Blat, LB)
Abstract Slides Video

Access the full session

Session thumbnail
Medical treatment in acute heart failure
Video

The Event

Event poster

Heart Failure 2026

11 May 2026 16:02 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
Timing matters: clinical outcomes of early sodium-glucose cotransporter-2 inhibitor initiation in acute heart failure
thumbnail
Congress Session
Medical treatment in acute heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources